G. M. Simpson
- Psychiatry and Mental health top 0.2%
- Clinical Psychology top 2%
- Pharmacology top 1%
- Philosophy top 0.5%
- Neurology top 2%
- Co-authors
- J. W. S. AngusBoris ZoubokG. GárdosMichael C. StevensT. Scott StroupIra D. GlickJosé M. CañiveM S Swartz
- Topics
- Schizophrenia research and treatment (16 papers)Bipolar Disorder and Treatment (6 papers)Pharmaceutical studies and practices (5 papers)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
G. M. Simpson
40 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Psychiatry and Mental health 3.6k
- Clinical Psychology 792
- Pharmacology 629
- Philosophy 586
- Neurology 556
Countries citing papers authored by G. M. Simpson
This map shows the geographic impact of G. M. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. M. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. M. Simpson more than expected).
Fields of papers citing papers by G. M. Simpson
This network shows the impact of papers produced by G. M. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. M. Simpson. The network helps show where G. M. Simpson may publish in the future.
Co-authorship network of co-authors of G. M. Simpson
This figure shows the co-authorship network connecting the top 25 collaborators of G. M. Simpson. A scholar is included among the top collaborators of G. M. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. M. Simpson. G. M. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Developmentbreakdown → | 512 |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 10 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | 23 | |
| 9 | 16 | |
| 10 | 125 | |
| 11 | Measurement of negative symptoms in schizophrenia. | 25 |
| 12 | Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients. | 19 |
| 13 | Comparative value of rating and self-rating scales in drug trials [proceedings]. | 1 |
| 14 | An early clinical and toxicity trial of EX 11-582A in chronic schizophrenia. | 10 |
| 15 | 4 | |
| 16 | 25 | |
| 17 | 20 | |
| 18 | 9 | |
| 19 | 4 | |
| 20 | 3 |
About G. M. Simpson
G. M. Simpson is a scholar working on Psychiatry and Mental health, Toxicology and Geriatrics and Gerontology, having authored 41 papers that have together received 4.4k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (6 papers) and Pharmaceutical studies and practices (5 papers). The work is most often cited by research in Psychiatry and Mental health (3.6k citations), Biological Psychiatry (247 citations) and Philosophy (586 citations). G. M. Simpson has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include J. W. S. Angus, Boris Zoubok, G. Gárdos, Michael C. Stevens, T. Scott Stroup, Ira D. Glick, José M. Cañive, M S Swartz, Matthew Byerly and Jeffrey A. Lieberman. Their work appears in journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.